669 related articles for article (PubMed ID: 27125761)
1. Oximes in organophosphate poisoning: 60 years of hope and despair.
Worek F; Thiermann H; Wille T
Chem Biol Interact; 2016 Nov; 259(Pt B):93-98. PubMed ID: 27125761
[TBL] [Abstract][Full Text] [Related]
2. The value of novel oximes for treatment of poisoning by organophosphorus compounds.
Worek F; Thiermann H
Pharmacol Ther; 2013 Aug; 139(2):249-59. PubMed ID: 23603539
[TBL] [Abstract][Full Text] [Related]
3. In silico and in vitro evaluation of two novel oximes (K378 and K727) in comparison to K-27 and pralidoxime against paraoxon-ethyl intoxication.
Arshad M; Fatmi MQ; Musilek K; Hussain A; Kuca K; Petroianu G; Kalasz H; Nurulain SM
Toxicol Mech Methods; 2018 Jan; 28(1):62-68. PubMed ID: 28722512
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in vitro analysis.
Worek F; Eyer P; Aurbek N; Szinicz L; Thiermann H
Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):226-34. PubMed ID: 17112559
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive evaluation of the efficacy of leading oxime therapies in guinea pigs exposed to organophosphorus chemical warfare agents or pesticides.
Wilhelm CM; Snider TH; Babin MC; Jett DA; Platoff GE; Yeung DT
Toxicol Appl Pharmacol; 2014 Dec; 281(3):254-65. PubMed ID: 25448441
[TBL] [Abstract][Full Text] [Related]
6. Limitations in current acetylcholinesterase structure-based design of oxime antidotes for organophosphate poisoning.
Kovalevsky A; Blumenthal DK; Cheng X; Taylor P; Radić Z
Ann N Y Acad Sci; 2016 Aug; 1378(1):41-49. PubMed ID: 27371941
[TBL] [Abstract][Full Text] [Related]
7. Post-exposure treatment with the oxime RS194B rapidly reactivates and reverses advanced symptoms of lethal inhaled paraoxon in macaques.
Rosenberg YJ; Wang J; Ooms T; Rajendran N; Mao L; Jiang X; Lees J; Urban L; Momper JD; Sepulveda Y; Shyong YJ; Taylor P
Toxicol Lett; 2018 Sep; 293():229-234. PubMed ID: 29129799
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
9. Probing the activity of a non-oxime reactivator for acetylcholinesterase inhibited by organophosphorus nerve agents.
Cadieux CL; Wang H; Zhang Y; Koenig JA; Shih TM; McDonough J; Koh J; Cerasoli D
Chem Biol Interact; 2016 Nov; 259(Pt B):133-141. PubMed ID: 27062893
[TBL] [Abstract][Full Text] [Related]
10. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
[TBL] [Abstract][Full Text] [Related]
11. Structural requirements for effective oximes--evaluation of kinetic in vitro data with phosphylated human AChE and structurally different oximes.
Worek F; Wille T; Koller M; Thiermann H
Chem Biol Interact; 2013 Mar; 203(1):125-8. PubMed ID: 22827894
[TBL] [Abstract][Full Text] [Related]
12. Effect of reversible ligands on oxime-induced reactivation of sarin- and cyclosarin-inhibited human acetylcholinesterase.
Scheffel C; Thiermann H; Worek F
Toxicol Lett; 2015 Feb; 232(3):557-65. PubMed ID: 25522658
[TBL] [Abstract][Full Text] [Related]
13. Interactions between xylene-linked carbamoyl bis-pyridinium mono-oximes and organophosphates inhibited-AChE: a kinetic study.
Sharma R; Gupta B; Acharya J; Kaushik MP; Ghosh KK
Toxicology; 2014 Feb; 316():1-8. PubMed ID: 24345352
[TBL] [Abstract][Full Text] [Related]
14. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
Aurbek N; Herkert NM; Koller M; Thiermann H; Worek F
Chem Biol Interact; 2010 Sep; 187(1-3):215-9. PubMed ID: 20105433
[TBL] [Abstract][Full Text] [Related]
15. Interactions between acetylcholinesterase, toxic organophosphorus compounds and a short series of structurally related non-oxime reactivators: Analysis of reactivation and inhibition kinetics in vitro.
Horn G; de Koning MC; van Grol M; Thiermann H; Worek F
Toxicol Lett; 2018 Dec; 299():218-225. PubMed ID: 30312685
[TBL] [Abstract][Full Text] [Related]
16. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.
Antonijevic B; Stojiljkovic MP
Clin Med Res; 2007 Mar; 5(1):71-82. PubMed ID: 17456837
[TBL] [Abstract][Full Text] [Related]
17. Organophosphorus compounds and oximes: a critical review.
Worek F; Thiermann H; Wille T
Arch Toxicol; 2020 Jul; 94(7):2275-2292. PubMed ID: 32506210
[TBL] [Abstract][Full Text] [Related]
18. Kinetic prerequisites of oximes as effective reactivators of organophosphate-inhibited acetylcholinesterase: a theoretical approach.
Worek F; Aurbek N; Wille T; Eyer P; Thiermann H
J Enzyme Inhib Med Chem; 2011 Jun; 26(3):303-8. PubMed ID: 20807085
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
Shih TM; Skovira JW; O'Donnell JC; McDonough JH
Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
[TBL] [Abstract][Full Text] [Related]
20. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
Eyer P; Szinicz L; Thiermann H; Worek F; Zilker T
Toxicology; 2007 Apr; 233(1-3):108-19. PubMed ID: 17010492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
